Additionally, in the context of pregnancy, studies indicate that BNP is a significant predictor of cardiovascular events in PAH patients associated with congenital heart disease (CHD), with levels ≥ 300 ng/L posing an independent risk [25]. This evidence concerns the gene NPPB and coronary artery disorder.